scispace - formally typeset
Search or ask a question

What is the best CBD oil for lung cancer? 

Answers from top 12 papers

More filters
Papers (12)Insight
Interestingly, some oils actually appeared to protect cancer cells from the effects of CBD.
CPT-11 proved to be effective for primary lung cancer.
This paper presents a novel alternative for the treatment of lung cancer.
Until specific preventive factors are identified, the best protection against lung cancer is still the avoidance of airborne carcinogens, especially tobacco smoke; second best is the consumption of a diet rich in fruits and vegetables.
In summary, compound 81 is a valuable candidate for anti-lung cancer therapy.
We found that pure CBD was as potent or more potent at reducing cancer cell viability as the most potent oil tested, suggesting that there is no “entourage” effect under these specific in vitro conditions.
Aloin is therefore a potential therapeutic agent for human lung cancer and is worthy of further investigation.
We suggest that HKDC1 is a novel potential therapeutic target for lung cancer.
LPB is a promising medicine for inhalation treatment of primary lung cancer.
Thus, providing a promising platform for lung cancer therapy.
This is a well-tolerated and active regimen for non-small cell lung cancer.
These results suggest that DHA is a potential natural product for the treatment of lung cancer.

Related Questions

How do endocannabinoids affect cancer cells?5 answersEndocannabinoids exert various effects on cancer cells by binding to cannabinoid receptors. Studies have shown that cannabinoids, including Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD), reduce cancer cell viability, inhibit proliferation, induce apoptosis, and suppress tumor growth. Specifically, cannabinoids have been found to decrease cell proliferation, tumor size, angiogenesis, adhesion, migration, and metastasis, while promoting cell cycle arrest, apoptosis, and autophagy in cancer cells and xenograft models. Additionally, cannabinoid compounds have shown potential in inhibiting tumorigenesis by targeting multiple levels of tumor progression through different signal transduction mechanisms, including inhibition of tumor cell proliferation, invasion, metastasis, angiogenesis, and chemoresistance, as well as induction of apoptosis and autophagy.
How can glucosinolates help with lung cancer treatment and or prevention?4 answersGlucosinolates, found in cruciferous vegetables, have been shown to have a beneficial effect on reducing the incidence of lung cancer. They contain biologically active substances that can inhibit neoplastic processes, enhance tumor cell apoptosis, and alter the detoxification process of carcinogenic compounds in the air. Observational studies have found an inverse association between cruciferous vegetable intake and lung cancer risk, and more studies are needed to investigate the association between urinary isothiocyanate (ITC) concentrations and lung cancer risk. Isothiocyanates (ITCs), which are derived from glucosinolates, have demonstrated anticarcinogenic bioactivity in animal models and have been shown to suppress reactive metabolite generation and decrease DNA adducts formation. In vitro studies have also reported the effects of ITCs on cell cycle modulation and proapoptotic effects. Understanding the pathways of associated proteins provides insight into the induction of apoptosis by ITCs.
What are the most effective treatments for lung cancer?5 answersThe most effective treatments for lung cancer include surgical resection, chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Surgical resection is the treatment of choice for early stage non-small cell lung carcinoma (NSCLC). Chemotherapy and/or immunotherapy are the standard treatments for patients with distant metastasis who do not have driver mutations. Targeted agents are used as the initial treatment for patients with driver mutations in key genes. Radiation therapy, either alone or in combination with chemotherapy, can be used to treat locoregionally advanced NSCLC. In addition, combination therapies involving photodynamic therapy (PDT) with surgery, radiotherapy, chemotherapy, targeted therapy, or immunotherapy have shown promise in the treatment of lung cancer. Nanoparticles and nanostructures have also been used to improve the effectiveness of chemotherapy and radiation therapy for lung cancer.
What are the most effective ways to treat lung cancer?5 answersThe most effective ways to treat lung cancer include surgical resection, chemotherapy, immunotherapy, radiation therapy, and targeted therapy. Surgical resection is the treatment of choice for early stage non-small cell lung carcinoma (NSCLC). Chemotherapy and/or immunotherapy are the standard treatments for patients with distant metastasis who do not have driver mutations. Targeted agents are used as initial treatment for patients with driver mutations in key genes. Radiation therapy, including stereotactic body radiation therapy, can be used for curative intent in early stage NSCLC. Immunotherapy, which stimulates the patient's immune system to destroy tumor cells, is an alternative treatment that shows promise in lung cancer. These treatment options can be combined with oncolytic virotherapy, using viruses to selectively infect and destroy cancer cells, to enhance effectiveness and protection against tumor relapse and metastasis. Image-guided percutaneous and transarterial therapies, such as thermal ablation and catheter-based treatments, are also valid treatment modalities for primary and metastatic lung cancer. Additionally, nano-based therapeutic systems are being explored for targeted delivery of chemotherapeutics, offering potential advancements in lung cancer treatment. Patient-derived tumor xenograft (PDX) models provide valuable tools for preclinical research and efficacy screening of new cancer drugs.
What are the most effective drugs currently available for the treatment of lung cancer?5 answersImmunotherapy drugs, including anti-CTLA-4 and PD-1/L1 inhibitors, have shown significant efficacy in the treatment of lung cancer. The drugs Ipilimumab (CTLA-4), Nivolumab, Pembrolizumab, and Durvalumab (PD-1/L1) are currently being used and have demonstrated positive outcomes in lung cancer patients. In addition to immunotherapy, combination therapies have emerged as effective treatment strategies. Four multi-therapy regimens, Erlotinib plus ramucirumab, Erlotinib plus bevacizumab, Carboplatin plus albumin-bound paclitaxel plus atezolizumab, and Nivolumab plus ipilimumab, have passed clinical trials and are being used as first-line treatments. Furthermore, some antipsychotics, such as trifluoperazine (TFP) and its synthetic analogs, have shown anticancer activity and potential as therapeutic options for lung cancer. Novel agents currently in development, such as lurbinectedin, Aurora A kinase inhibitors, PARP inhibitors, CDK 4/6 inhibitors, and agents targeting DLL3 and angiogenesis, hold promise for the future treatment of lung cancer.
Can you use a nebulizer with lung cancer?5 answers

See what other people are reading

Why trypan blue is added to cell culture haemocytometer?
4 answers
Trypan blue is added to cell culture haemocytometer for cell viability assessment and counting. It is a widely used dye that stains dead cells blue, allowing for easy differentiation between live and dead cells under a microscope. The combination of trypan blue with a haemocytometer is considered the standard approach to estimate cell population density and assess viability in 2D and 3D cultures. This method provides a rapid and convenient way to determine the overall viability of cells in a culture before experiments or to quantify cell death post-treatment with cytotoxic agents. Additionally, trypan blue staining can be adapted for in situ staining of adherent cells on ELISA plates, offering a practical tool for preliminary cell viability assessment in high-throughput settings.
What is the current state of research on Pomiferin as an antineoplastic agent?
4 answers
Pomiferin, a natural product from Osage Orange, has shown promising potential as an antineoplastic agent. It has been identified as an autophagy activator that overcomes innate and acquired drug resistance in cancer. Additionally, heteroleptic copper(II) complexes containing pomiferin have demonstrated significant cytotoxicity against various cancer cell lines, including cisplatin-resistant ovarian carcinoma. Furthermore, studies on ponicidin, a diterpenoid similar to pomiferin, have highlighted its antioxidant and anticancer properties, suggesting the potential of pomiferin as a cancer chemotherapeutic agent. Moreover, mangiferin, another natural compound, has been explored for its anti-cancer properties and bioavailability enhancement strategies, indicating the promising nature of natural compounds like pomiferin in cancer treatment. Overall, research indicates that pomiferin holds great promise as an effective agent in combating cancer.
What is the current smoking prevalence in the population being studied in the retrospective cohort screening study?
4 answers
The current smoking prevalence in the population studied in the retrospective cohort screening study was 24.6%. Additionally, in another study, 6.37% of postmenopausal women were current smokers. These findings indicate a significant proportion of smokers in the populations under investigation. The data suggests that a considerable portion of individuals in these cohorts were actively smoking during the respective study periods. This prevalence of current smokers highlights the importance of addressing smoking cessation interventions and promoting lung cancer screening among high-risk groups to mitigate the associated health risks and improve outcomes.
What is breast cancer?
5 answers
Breast cancer is a prevalent malignancy in women, arising from various cell types within the breast. It is characterized by abnormal cell growth that can spread to surrounding tissues and other parts of the body. The disease is categorized based on tumor size and metastasis status, with various treatment options available, including FDA-approved drugs with specific mechanisms of action. Breast cancer is a significant health concern globally, being the most common cancer in women and a leading cause of cancer-related deaths. The incidence of breast cancer has been on the rise in recent years, emphasizing the importance of prevention, early diagnosis, and effective treatment strategies to combat this disease.
What is the function of messenger RNA (mRNA) in epigenetics mechanisms?
5 answers
Messenger RNA (mRNA) plays a crucial role in epigenetic mechanisms by undergoing modifications known as epitranscriptomics. These modifications, such as N6-methyladenosine (m6A), N1-methyladenosine (m1A), and N7-methylguanosine (m7G), dynamically regulate gene expression. Epitranscriptomic markers on mRNA have been linked to various diseases, including cancers, chronic lung diseases, and neurological disorders. Additionally, mRNA modifications have been associated with controlling basic cellular processes, brain development, circadian cycles, metabolism, and sex differentiation. The interplay between RNA modifications and regulatory processes influences cellular biology, impacting protein complex formation, genomic stability, and disease states like cancers. Therefore, mRNA modifications are essential in understanding the molecular mechanisms underlying biological processes and disease development.
How does lung adenocarsinoma start to form?
4 answers
Lung adenocarcinoma, the most common form of lung cancer, initiates from precursor lesions like atypical adenomatous hyperplasia (AAH) and progresses through stages like adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) before becoming invasive adenocarcinoma. The transformation of progenitor cells accumulating genetic abnormalities is a key factor in the development of lung adenocarcinoma. Chronic exposure to cigarette smoke, the primary cause of lung adenocarcinoma, triggers a stepwise transition from normal lung tissue to the appearance of neoplastic cells, involving a "field of injury" concept that explains the early events in smoking-induced lung adenocarcinoma development. These early events involve the emergence of cells resembling alveolar type 2 cells that evolve into stem-like cells, with upregulated genes related to energy metabolism and ribosome synthesis promoting progression.
How essentials oils can help with Complementary therapies?
5 answers
Essential oils (EOs) are integral to complementary therapies like aromatherapy, offering a natural approach to enhance physical and psychological well-being. These oils, derived from various plant parts, contain bioactive compounds like terpenes, aldehydes, and phenols, known for their diverse therapeutic properties. EOs can effectively alleviate conditions such as depression, headache, insomnia, and respiratory problems by directly affecting physiological processes in the body. The global market for essential oil-based therapy is growing, with EOs being used for pain management, inflammation, psychological disorders, and even COVID-19 symptoms. Despite their benefits, caution is advised as EOs can be toxic if not used safely under professional guidance. Overall, EOs play a significant role in complementary therapies by offering a natural and holistic approach to improving overall health and well-being.
How does cannabis matrix effect can impact the analytical results?
4 answers
The cannabis matrix effect can significantly impact analytical results by causing interference in the detection of cannabinoids. Factors such as the presence of chocolate matrices can lead to signal suppression and lower recovery rates of cannabinoid analytes. Different storage conditions in biological matrices can affect the stability of cannabis compounds, influencing the accuracy of testing for intoxication. Analytical procedures for detecting low concentrations of cannabinoids in saliva, blood, or urine require meticulous sample preparation due to the matrix effect. The matrix effect is highly dependent on sample preparation methods, with variations observed even among structurally similar synthetic cannabinoids. Understanding and accounting for the matrix effect is crucial in cannabinoid analyses to ensure accurate and reliable results.
What is the role of crosstalk between different post-translational modifications in lung cancer pathogenesis?
5 answers
Crosstalk between different post-translational modifications (PTMs) plays a crucial role in lung cancer pathogenesis. Studies have shown that proteins in lung cancer cells undergo various PTMs like phosphorylation, methylation, and acetylation, which collectively regulate cell signaling pathways. This intricate network of PTMs influences key cellular processes such as stem-like properties maintenance, gene expression control, and epithelial-mesenchymal transition in lung cancer cells. The interplay between PTMs can lead to the activation or inhibition of critical proteins involved in oncogenic signaling pathways, highlighting potential drug targets for combination therapies in lung cancer treatment. Understanding the crosstalk between different PTMs provides insights into the molecular mechanisms underlying lung cancer progression and offers avenues for developing targeted therapeutic approaches to combat this disease.
Why DMSO toxic to cells?
4 answers
Dimethyl sulfoxide (DMSO) exhibits toxicity to cells due to various reasons outlined in the provided contexts. Studies have shown that high concentrations of DMSO induce cell death mechanisms, including cleavage of caspase-3 and PARP-1. Furthermore, DMSO has been associated with significant clinical side effects in patients receiving cell-therapy products, affecting cardiovascular, neurological, gastrointestinal, and allergic systems. The toxicity of DMSO is evident in its impact on gene expression, microRNA deregulation, and epigenetic changes in tissues like cardiac and hepatic microtissues. Despite being widely used, DMSO can cause adverse reactions such as nausea, chills, cardiac arrhythmias, and neurological symptoms, leading to concerns about its safety and cytotoxicity. Therefore, the toxic effects of DMSO on cells are multifaceted, ranging from molecular disruptions to clinical manifestations.
What are the common pathogenic features of copd and lung cancer?
4 answers
Common pathogenic features of COPD and lung cancer include exposure to tobacco smoke as a major shared risk factor, immune dysfunction, lung microbiome alterations, genetic susceptibility, and epigenetic factors like DNA methylation and microRNA expression. Both diseases exhibit chronic inflammation, which is crucial in driving lung cancer development, especially in the presence of COPD. Additionally, oxidative stress, premature pulmonary failure, and genetic predisposition contribute to the development of both COPD and lung cancer. RNA-binding proteins play a role in regulating inflammatory mediators and are implicated in the pathogenic mechanisms shared by COPD and lung cancer, highlighting the need for further research to identify potential biomarkers and therapeutic targets.